TABLE 1.

Tool Creation

Attribute	Levels	Notes
Success rate	T: ~73%38,39 I: 45% to 84%28–30,31 S: 97% to 100%32,33	• Success rate was typically defined as the absence of subsequent injections or surgical release,28 complete resolution of symptoms for the entirety of follow-up29 • There is significant variation in definition of and follow-up for success rate of surgery in the literature. This review does not differentiate between digit involved or comorbid factors
Complication rate	T: Rare to none39 I: 0% to 1.6%29‘30 S: 3% to 37% (major: 3%, minor: 28%)27,34	• Primary reported complication of therapy is stiffness (up to 27%) that “resolved quickly”39 • Most common complications of injections include cellulitis,30 steroid flare, fat necrosis36 • Most common complications of surgery include major: synovial fluid cyst requiring excision, arthrofibrosis; minor: wound complications, stiffness, pain27
Immobilization time	T: nightly for ~3–9 wk I: none S: none	• Levels based on literature review demonstrating a range of immobilization from 3 to 9 wk in the therapy group37
Pain associated with treatment	T: + I: ++ S: +++	• There is significant variation in definition and follow-up of pain associated with treatment in the literature5,27,35
Treatment cost	T: $ $ I: $ S: $ $ $2	• Cost was discussed relative to other levels. When available, this discussion was put into the context of a patient’s remaining deductible
Anesthesia use	T: none I: none S: local or MAC + local	• Levels based on literature review and general practice patterns6

I, injection; S, open surgical release; T, therapy and orthosis.